Richard Malabre
Comptroller/Controller/Auditor bij AKEBIA THERAPEUTICS, INC.
Vermogen: 297 854 $ op 30-04-2024
Profiel
Richard C.
Malabre is currently the Chief Accounting Officer at Akebia Therapeutics, Inc. Prior to this, he was the Chief Financial Officer & Treasurer at Ultivue, Inc. from 2021 to 2023.
Malabre has a graduate degree from the Massachusetts Institute of Technology and an undergraduate degree from Trinity College (Connecticut).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-01-2024 | 223 950 ( 0.11% ) | 297 854 $ | 30-04-2024 |
Actieve functies van Richard Malabre
| Bedrijven | Functie | Begin |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 08-01-2024 |
Eerdere bekende functies van Richard Malabre
| Bedrijven | Functie | Einde |
|---|---|---|
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Financieel Directeur/CFO | 01-09-2023 |
Opleiding van Richard Malabre
| Massachusetts Institute of Technology | Graduate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Ultivue, Inc.
Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Health Technology |